These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35862462)

  • 21. Clinico-pathological significance of suspicious peritoneal cytology in endometrial cancer.
    Matsuo K; Matsuzaki S; Miller H; Nusbaum DJ; Walia S; Matsuzaki S; Shimada M; Klar M; Roman LD
    J Surg Oncol; 2021 Sep; 124(4):687-698. PubMed ID: 34118157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Impact of Positive Peritoneal Cytology on the Survival Rates of Early-Stage-Disease Endometrial Cancer Patients: Systematic Review and Meta-Analysis.
    Pergialiotis V; Panagiotopoulos M; Koutras A; Daras A; Ntounis T; Liontos M; Daskalakis G; Thomakos N
    Medicina (Kaunas); 2024 Apr; 60(5):. PubMed ID: 38792916
    [No Abstract]   [Full Text] [Related]  

  • 23. Positive peritoneal cytology is an independent risk-factor in early stage endometrial cancer.
    Garg G; Gao F; Wright JD; Hagemann AR; Mutch DG; Powell MA
    Gynecol Oncol; 2013 Jan; 128(1):77-82. PubMed ID: 23032094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reviving peritoneal cytology: Exploring its role in endometrial cancer molecular classification.
    Villiger AS; Zurbriggen S; Imboden S; Solass W; Christe L; Saner FAM; Gmür A; Rau TT; Mueller MD; Siegenthaler F
    Gynecol Oncol; 2024 Mar; 182():148-155. PubMed ID: 38266401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of peritoneal cytology in low-intermediate risk endometrial cancer.
    Scott SA; van der Zanden C; Cai E; McGahan CE; Kwon JS
    Gynecol Oncol; 2017 May; 145(2):262-268. PubMed ID: 28359690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognosis and adjuvant chemotherapy for patients with positive peritoneal cytology in stage IA endometrial cancer.
    Kanno M; Yunokawa M; Nakabayashi M; Omi M; Ikki A; Mizusaki M; Nishimura M; Shimizu Y; Okamoto K; Tanaka Y; Fusegi A; Netsu S; Kurita T; Aoki Y; Tanigawa T; Matoda M; Okamoto S; Nomura H; Omatsu K; Sugiyama Y; Utsugi K; Takeshima N; Kanao H
    Sci Rep; 2022 Jan; 12(1):166. PubMed ID: 34997003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of peritoneal washing cytology in gynecologic malignancies: a controversial issue.
    Binesh F; Akhavan A; Behniafard N; Zabihi S; Hosseinizadeh E
    Asian Pac J Cancer Prev; 2014; 15(21):9405-10. PubMed ID: 25422232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective Multicenter Trial Assessing the Impact of Positive Peritoneal Cytology Conversion on Oncological Outcome in Patients with Endometrial Cancer Undergoing Minimally Invasive Surgery with the use of an Intrauterine Manipulator : Positive Peritoneal Cytology Conversion and Its Association with Oncological Outcome in Endometrial Cancer.
    Siegenthaler F; Johann S; Imboden S; Samartzis N; Ledermann-Liu H; Sarlos D; Eberhard M; Mueller MD
    Ann Surg Oncol; 2022 Dec; 29(13):8320-8333. PubMed ID: 36057902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of Malignant Peritoneal Cytology on Survival of Women with Uterine Sarcoma.
    Matsuo K; Matsuzaki S; Nusbaum DJ; Ki S; Chang EJ; Klar M; Roman LD
    Ann Surg Oncol; 2021 Mar; 28(3):1740-1748. PubMed ID: 33063261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of adjuvant therapy in stage IIIC2 endometrial cancer.
    Bogani G; Cappuccio S; Casarin J; Narasimhulu DMM; Cilby WA; Glaser GE; Weaver AL; McGree ME; Keeney GL; Weroha J; Petersen IA; Mariani A
    Int J Gynecol Cancer; 2020 Aug; 30(8):1169-1176. PubMed ID: 32646864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer.
    Havrilesky LJ; Cragun JM; Calingaert B; Alvarez Secord A; Valea FA; Clarke-Pearson DL; Berchuck A; Soper JT
    Gynecol Oncol; 2007 Feb; 104(2):401-5. PubMed ID: 17014898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Therapeutic Management of Early Stages].
    Canlorbe G; Lecointre L; Chauvet P; Azaïs H; Fauvet R; Uzan C
    Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):287-303. PubMed ID: 32004786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical implications of positive peritoneal cytology in endometrial cancer].
    Ren YL; Wang HY; Shan BE; Ping B; Shi DR
    Zhonghua Fu Chan Ke Za Zhi; 2011 Aug; 46(8):595-9. PubMed ID: 22169518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A qualitative systematic review of the significance of adjuvant therapy in patients with low-risk endometrial cancer presenting positive peritoneal cytology: a relevant study to the guideline update for endometrial cancer by the Japan society of gynecologic oncology guideline committee.
    Shigeta S; Konno Y; Terai Y; Morisada T; Tokunaga H; Baba T; Kobayashi Y; Nagase S
    Jpn J Clin Oncol; 2024 Feb; 54(2):217-220. PubMed ID: 37823222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proposal of an endometrial cancer staging schema with stage-specific incorporation of malignant peritoneal cytology.
    Matsuo K; Matsuzaki S; Roman LD; Klar M; Wright JD
    Am J Obstet Gynecol; 2021 Mar; 224(3):319-321. PubMed ID: 33127431
    [No Abstract]   [Full Text] [Related]  

  • 36. Controversy on Positive Peritoneal Cytology of Endometrial Carcinoma.
    Liu YS; Wang HM; Gao Y
    Comput Math Methods Med; 2022; 2022():1906769. PubMed ID: 35401781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The significance of peritoneal cytology in uterine cervix and endometrial cancer.
    Kashimura M; Sugihara K; Toki N; Matsuura Y; Kawagoe T; Kamura T; Kaku T; Tsuruchi N; Nakashima H; Sakai H
    Gynecol Oncol; 1997 Dec; 67(3):285-90. PubMed ID: 9441776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of uterine manipulators in minimally invasive hysterectomy for endometrial cancer: A systematic review and meta-analysis.
    Meng Y; Liu Y; Lin S; Cao C; Wu P; Gao P; Zhi W; Peng T; Gui L; Wu P
    Eur J Surg Oncol; 2020 Jul; 46(7):1225-1232. PubMed ID: 32360066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histologic grade and peritoneal cytology as prognostic factors in type 1 endometrial cancer.
    Tanaka K; Kobayashi Y; Sugiyama J; Yamazaki T; Dozono K; Watanabe M; Shibuya H; Nishigaya Y; Momomura M; Matsumoto H; Umezawa S; Takamatsu K; Iwashita M
    Int J Clin Oncol; 2017 Jun; 22(3):533-540. PubMed ID: 28083737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Embryologically based radical hysterectomy as peritoneal mesometrial resection (PMMR) with pelvic and para-aortic lymphadenectomy for loco-regional tumor control in endometrial cancer: first evidence for efficacy.
    Kimmig R; Iannaccone A; Aktas B; Buderath P; Heubner M
    Arch Gynecol Obstet; 2016 Jul; 294(1):153-60. PubMed ID: 26596725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.